Machilin D, a Lignin Derived from Saururus Chinensis, Suppresses Breast Cancer Stem Cells and Inhibits NF-κB Signaling
Overview
Molecular Biology
Affiliations
Cancer stem cells are responsible for breast cancer initiation, metastasis, and relapse. Targeting breast cancer stem cells (BCSCs) using phytochemicals is a good strategy for the treatment of cancer. A silica gel, a reversed-phase C18 column (ODS), a Sephadex LH-20 gel, thin layer chromatography, and high-performance liquid chromatography (HPLC) were used for compound isolation from Saururus chinensis extracts. The isolated compound was identified as machilin D by mass spectrometry and nuclear magnetic resonance (NMR). Machilin D inhibited the growth and mammosphere formation of breast cancer cells and inhibited tumor growth in a xenograft mouse model. Machilin D reduced the proportions of CD44/CD24 and aldehyde dehydrogenase 1 (ALDH1)-positive cells. Furthermore, this compound reduced the nuclear localization of the NF-κB protein and decreased the IL-6 and IL-8 secretion in mammospheres. These results suggest that machilin D blocks IL-6 and IL-8 signaling and induces CSC death and thus may be a potential agent targeting BCSCs.
Current and potential future biological uses of (Falc.) Lipsch: A comprehensive review.
Elnour A, Abdurahman N Heliyon. 2024; 10(18):e37790.
PMID: 39323795 PMC: 11422592. DOI: 10.1016/j.heliyon.2024.e37790.
MyD88 signaling pathways: role in breast cancer.
Zheng H, Wu X, Guo L, Liu J Front Oncol. 2024; 14:1336696.
PMID: 38347830 PMC: 10859757. DOI: 10.3389/fonc.2024.1336696.
Targeting Cervical Cancer Stem Cells by Phytochemicals.
Tripathi T, Yadav J, Janjua D, Chaudhary A, Joshi U, Senrung A Curr Med Chem. 2024; 31(32):5222-5254.
PMID: 38288813 DOI: 10.2174/0109298673281823231222065616.
Song J, Mun S, Yang H, Kwon Y, Kim S, Song M Viruses. 2024; 16(1).
PMID: 38275951 PMC: 10821076. DOI: 10.3390/v16010016.
Ordaz-Ramos A, Tellez-Jimenez O, Vazquez-Santillan K Front Cell Dev Biol. 2023; 11:1221175.
PMID: 37492224 PMC: 10363614. DOI: 10.3389/fcell.2023.1221175.